Search Legislation

The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)
 Help about opening options

Opening OptionsExpand opening options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Amendment of regulation 41 of the principal Regulations

This section has no associated Explanatory Memorandum

21.  In regulation 41 of the principal Regulations (application and effect of manufacturing authorisation)—

(a)in paragraph (b), omit “and”; and

(b)after paragraph (b), insert the following paragraph—

(bb)in the case of an authorisation relating to the inactivation of viral or non-conventional agents, the manufacturing process; and.

Back to top

Options/Help